Ningrong Zhang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Signaling Pathway

Cell Cycle Arrest

Chronic Kidney Disease

Top Venues

Assay and drug development technologies

This page only lists publications with an associated author ORCID identifier.

Publications

Ningrong Zhang, Li Zang
MiR-22-3p Inhibits 5-Fluorouracil Resistance in Cholangiocarcinoma Cells Through PTEN/PI3K/AKT Axis. Assay and drug development technologies (2024)
Ningrong Zhang, Li Zang
MiR-22-3p Inhibits 5-Fluorouracil Resistance in Cholangiocarcinoma Cells Through PTEN/PI3K/AKT Axis. Assay and drug development technologies 22 (5) (2024)
Ningrong Zhang, Li Zang
MiR-22-3p Inhibits 5-Fluorouracil Resistance in Cholangiocarcinoma Cells Through PTEN/PI3K/AKT Axis. Assay and drug development technologies 22 (5) (2024)